Effective treatment of collecting duct carcinoma in a recipient of a kidney transplant: A case report.

IF 2.5 4区 医学 Q3 ONCOLOGY Oncology Letters Pub Date : 2024-09-03 DOI:10.3892/ol.2024.14661
Tabata Carolina Faria Nascimento de Assis,Liane Rapatoni,Flavio Nogueira Segato,Barbhara Thais Maciel Pontes,Valdair Francisco Muglia,Miguel Moyses Neto,Elen Almeida Romao
{"title":"Effective treatment of collecting duct carcinoma in a recipient of a kidney transplant: A case report.","authors":"Tabata Carolina Faria Nascimento de Assis,Liane Rapatoni,Flavio Nogueira Segato,Barbhara Thais Maciel Pontes,Valdair Francisco Muglia,Miguel Moyses Neto,Elen Almeida Romao","doi":"10.3892/ol.2024.14661","DOIUrl":null,"url":null,"abstract":"Collecting duct carcinoma (CDC) is a rare disease associated with a high mortality rate. The present study describes the case of a recipient of a kidney transplant with metastatic allograft CDC whose treatment was successful. The patient underwent nephrectomy, and chemotherapy with gemcitabine and cisplatin, while undergoing haemodialysis treatment and remained in remission after 6 years of follow-up. There is a lack of information about the treatment and clinical management of CDC; however, the combination of gemcitabine and cisplatin remains as first-line therapy. The challenge of this case was integrating chemotherapy sessions with dialysis therapy to maintain the effectiveness, tolerability and safety of the oncological treatment. In the present case report, the success of chemotherapy with gemcitabine and cisplatin was demonstrated in a metastatic renal allograft CDC in a patient with end-stage renal disease, with few side effects and no recurrence of the disease 6 years after the end of treatment.","PeriodicalId":19503,"journal":{"name":"Oncology Letters","volume":"55 1","pages":"528"},"PeriodicalIF":2.5000,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Letters","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3892/ol.2024.14661","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Collecting duct carcinoma (CDC) is a rare disease associated with a high mortality rate. The present study describes the case of a recipient of a kidney transplant with metastatic allograft CDC whose treatment was successful. The patient underwent nephrectomy, and chemotherapy with gemcitabine and cisplatin, while undergoing haemodialysis treatment and remained in remission after 6 years of follow-up. There is a lack of information about the treatment and clinical management of CDC; however, the combination of gemcitabine and cisplatin remains as first-line therapy. The challenge of this case was integrating chemotherapy sessions with dialysis therapy to maintain the effectiveness, tolerability and safety of the oncological treatment. In the present case report, the success of chemotherapy with gemcitabine and cisplatin was demonstrated in a metastatic renal allograft CDC in a patient with end-stage renal disease, with few side effects and no recurrence of the disease 6 years after the end of treatment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
有效治疗肾移植受者的集合管癌:病例报告。
集合管癌(CDC)是一种死亡率很高的罕见疾病。本研究描述了一例患有转移性同种异体 CDC 的肾移植受者,其治疗取得了成功。患者在接受血液透析治疗的同时,接受了肾切除术、吉西他滨和顺铂化疗,随访 6 年后病情仍在缓解。目前缺乏有关 CDC 治疗和临床管理的信息,但吉西他滨和顺铂联合疗法仍是一线疗法。本病例面临的挑战是将化疗疗程与透析治疗相结合,以保持肿瘤治疗的有效性、耐受性和安全性。在本病例报告中,吉西他滨和顺铂联合化疗成功治疗了一名终末期肾病患者的转移性肾异位移植 CDC,副作用小,且在治疗结束 6 年后没有复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Oncology Letters
Oncology Letters ONCOLOGY-
CiteScore
5.70
自引率
0.00%
发文量
412
审稿时长
2.0 months
期刊介绍: Oncology Letters is a monthly, peer-reviewed journal, available in print and online, that focuses on all aspects of clinical oncology, as well as in vitro and in vivo experimental model systems relevant to the mechanisms of disease. The principal aim of Oncology Letters is to provide the prompt publication of original studies of high quality that pertain to clinical oncology, chemotherapy, oncogenes, carcinogenesis, metastasis, epidemiology and viral oncology in the form of original research, reviews and case reports.
期刊最新文献
Immunotherapy beyond progression following first‑line chemotherapy plus immunotherapy in advanced non‑small cell lung cancer: A retrospective study. Molecular characteristics, clinical significance and cancer‑immune interactions of pyroptosis‑related genes in colorectal cancer. The role of IL‑17, IFN‑γ, 4‑1BBL and tumour‑infiltrating lymphocytes in the occurrence, development and prognosis of pancreatic cancer. Network pharmacology and molecular docking reveal the mechanism of action of Bergapten against non‑small cell lung cancer. A novel algorithm for the detection of microsatellite instability in endometrial cancer using next‑generation sequencing data.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1